Search

866-361-3032

Tamper-Resistant Prescription Drugs - Canadian Update

Posted Date: 
Friday, June 26, 2015

This news update regarding tamper-resistant prescription drugs, is brought to you by Health Canada.

Health Canada today published a Notice of Pre-Consultation in Canada Gazette, Part I, seeking stakeholder feedback on draft Tamper-Resistant Properties of Drugs Regulations. The draft regulations would require that all controlled release oxycodone products have tamper-resistant properties before they can be sold in Canada.

These draft regulations build upon the numerous initiatives the Government is supporting to combat prescription drug abuse. The Government of Canada invests approximately $130 million a year to address addictions and drug abuse in Canada under the National Anti-Drug Strategy. These funds contribute to developing tangible and effective solutions to the problems of drug addiction. In 2014, the government committed over $44 million over five years to expand the focus of the National Anti-Drug Strategy from illicit drugs to include measures to address prescription drug abuse.

To learn more about tamper-resistant prescription drugs, please follow the Health Canada link above.  Please contact Nexreg for DIN registrations.

 

Testimonial

I am very satisfied with the work provided by Nexreg. The work has been through, timely and reasonable. Additionally, both Mike Harvey and Nazifa Beganovic are very knowledgeable. Mike and Nazifa's efforts have been an essential part of getting our MSDS program on track and positioned for the Global Harmonized System.
Jack Cover, Bonsal American, Inc.